annual CFI:
-$274.39M+$228.13M(+45.40%)Summary
- As of today (June 28, 2025), MDGL annual cash flow from investing activities is -$274.39 million, with the most recent change of +$228.13 million (+45.40%) on December 31, 2024.
- During the last 3 years, MDGL annual CFI has fallen by -$269.33 million (-5328.01%).
- MDGL annual CFI is now -232.76% below its all-time high of $206.69 million, reached on December 31, 2022.
Performance
MDGL Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$163.88M+$211.83M(+441.77%)Summary
- As of today (June 28, 2025), MDGL quarterly cash flow from investing activities is $163.88 million, with the most recent change of +$211.83 million (+441.77%) on March 31, 2025.
- Over the past year, MDGL quarterly CFI has increased by +$65.83 million (+67.13%).
- MDGL quarterly CFI is now at all-time high.
Performance
MDGL quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$208.56M+$65.83M(+23.99%)Summary
- As of today (June 28, 2025), MDGL TTM cash flow from investing activities is -$208.56 million, with the most recent change of +$65.83 million (+23.99%) on March 31, 2025.
- Over the past year, MDGL TTM CFI has increased by +$9.04 million (+4.16%).
- MDGL TTM CFI is now -200.91% below its all-time high of $206.69 million, reached on December 31, 2022.
Performance
MDGL TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
MDGL Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +45.4% | +67.1% | +4.2% |
| 3 y3 years | -5328.0% | +193.0% | -347.3% |
| 5 y5 years | -993.6% | +224.8% | -346.4% |
MDGL Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -232.8% | +45.4% | at high | +145.3% | -200.9% | +64.6% |
| 5 y | 5-year | -232.8% | +45.4% | at high | +145.3% | -200.9% | +64.6% |
| alltime | all time | -232.8% | +45.4% | at high | +145.3% | -200.9% | +64.6% |
MDGL Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $163.88M(-441.8%) | -$208.56M(-24.0%) |
| Dec 2024 | -$274.39M(-45.4%) | -$47.95M(-76.3%) | -$274.39M(-53.4%) |
| Sep 2024 | - | -$202.39M(+65.8%) | -$588.56M(+75.2%) |
| Jun 2024 | - | -$122.10M(-224.5%) | -$335.97M(+54.4%) |
| Mar 2024 | - | $98.05M(-127.1%) | -$217.60M(-56.7%) |
| Dec 2023 | -$502.52M(-343.1%) | -$362.12M(-821.4%) | -$502.52M(+579.0%) |
| Sep 2023 | - | $50.20M(-1445.1%) | -$74.01M(+25.3%) |
| Jun 2023 | - | -$3.73M(-98.0%) | -$59.07M(+63.6%) |
| Mar 2023 | - | -$186.86M(-381.5%) | -$36.10M(-117.5%) |
| Dec 2022 | $206.69M(-4188.7%) | $66.39M(+1.9%) | $206.69M(+32.5%) |
| Sep 2022 | - | $65.14M(+238.6%) | $155.94M(+19.1%) |
| Jun 2022 | - | $19.24M(-65.6%) | $130.90M(+55.2%) |
| Mar 2022 | - | $55.93M(+257.5%) | $84.33M(-1768.3%) |
| Dec 2021 | -$5.05M(-103.2%) | $15.64M(-61.0%) | -$5.05M(-80.2%) |
| Sep 2021 | - | $40.09M(-246.7%) | -$25.50M(-187.4%) |
| Jun 2021 | - | -$27.32M(-18.3%) | $29.17M(-61.6%) |
| Mar 2021 | - | -$33.46M(+597.5%) | $75.86M(-52.5%) |
| Dec 2020 | $159.78M(+420.3%) | -$4.80M(-105.1%) | $159.78M(+19.2%) |
| Sep 2020 | - | $94.75M(+389.3%) | $134.07M(+98.4%) |
| Jun 2020 | - | $19.36M(-61.6%) | $67.58M(-20.2%) |
| Mar 2020 | - | $50.46M(-265.4%) | $84.66M(+175.7%) |
| Dec 2019 | $30.71M(-108.1%) | -$30.51M(-207.9%) | $30.71M(-64.4%) |
| Sep 2019 | - | $28.27M(-22.4%) | $86.20M(-152.5%) |
| Jun 2019 | - | $36.44M(-1143.8%) | -$164.09M(-41.7%) |
| Mar 2019 | - | -$3.49M(-114.0%) | -$281.44M(-26.0%) |
| Dec 2018 | -$380.08M(+1627.1%) | $24.99M(-111.3%) | -$380.08M(-4.7%) |
| Sep 2018 | - | -$222.03M(+174.4%) | -$398.98M(+105.8%) |
| Jun 2018 | - | -$80.91M(-20.8%) | -$193.84M(+70.7%) |
| Mar 2018 | - | -$102.12M(-1778.3%) | -$113.57M(+416.1%) |
| Dec 2017 | -$22.01M(-200.1%) | $6.08M(-136.0%) | -$22.01M(+22.2%) |
| Sep 2017 | - | -$16.89M(+2509.9%) | -$18.01M(-267.0%) |
| Jun 2017 | - | -$647.00K(-93.9%) | $10.79M(-5.7%) |
| Mar 2017 | - | -$10.56M(-204.8%) | $11.44M(-48.0%) |
| Dec 2016 | $21.99M(>+9900.0%) | $10.08M(-15.4%) | $21.99M(+84.6%) |
| Sep 2016 | - | $11.91M(>+9900.0%) | $11.91M(-19.0%) |
| Jun 2016 | - | $0.00(0.0%) | $14.70M(-276.8%) |
| Mar 2016 | - | $0.00(0.0%) | -$8.32M(<-9900.0%) |
| Dec 2015 | $0.00 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2015 | - | $14.70M(-163.9%) | -$930.00K(-98.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2015 | - | -$23.02M(-376.8%) | -$51.21M(+206.4%) |
| Mar 2015 | - | $8.32M(-994.3%) | -$16.72M(+89.2%) |
| Dec 2014 | -$8.84M(-64.2%) | -$930.00K(-97.4%) | -$8.84M(-61.7%) |
| Sep 2014 | - | -$35.58M(-410.0%) | -$23.06M(-209.7%) |
| Jun 2014 | - | $11.48M(-29.1%) | $21.02M(-25.4%) |
| Mar 2014 | - | $16.20M(-206.9%) | $28.16M(-214.2%) |
| Dec 2013 | -$24.65M(+147.9%) | -$15.15M(-278.4%) | -$24.65M(+726.4%) |
| Sep 2013 | - | $8.49M(-54.4%) | -$2.98M(-83.7%) |
| Jun 2013 | - | $18.62M(-150.9%) | -$18.32M(-44.9%) |
| Mar 2013 | - | -$36.62M(-661.6%) | -$33.24M(+234.3%) |
| Dec 2012 | -$9.94M(-206.6%) | $6.52M(-195.3%) | -$9.94M(-382.2%) |
| Sep 2012 | - | -$6.84M(-285.0%) | $3.52M(-79.4%) |
| Jun 2012 | - | $3.70M(-127.8%) | $17.07M(-2260.9%) |
| Mar 2012 | - | -$13.32M(-166.6%) | -$790.00K(-108.5%) |
| Dec 2011 | $9.33M(-147.1%) | $19.99M(+198.0%) | $9.33M(-183.8%) |
| Sep 2011 | - | $6.71M(-147.4%) | -$11.14M(-64.2%) |
| Jun 2011 | - | -$14.16M(+342.3%) | -$31.08M(+35.1%) |
| Mar 2011 | - | -$3.20M(+567.1%) | -$23.00M(+16.2%) |
| Dec 2010 | -$19.80M(-194.1%) | -$480.00K(-96.4%) | -$19.80M(+752.8%) |
| Sep 2010 | - | -$13.24M(+117.5%) | -$2.32M(-110.3%) |
| Jun 2010 | - | -$6.09M(<-9900.0%) | $22.59M(-48.1%) |
| Mar 2010 | - | $0.00(-100.0%) | $43.52M(+106.7%) |
| Dec 2009 | $21.05M(-188.9%) | $17.00M(+45.6%) | $21.05M(-215.6%) |
| Sep 2009 | - | $11.68M(-21.3%) | -$18.20M(-40.0%) |
| Jun 2009 | - | $14.84M(-166.1%) | -$30.32M(-33.7%) |
| Mar 2009 | - | -$22.47M(+1.0%) | -$45.76M(+93.2%) |
| Dec 2008 | -$23.69M(-319.6%) | -$22.25M(+4911.7%) | -$23.69M(+929.4%) |
| Sep 2008 | - | -$444.00K(-25.5%) | -$2.30M(-8.6%) |
| Jun 2008 | - | -$596.00K(+50.9%) | -$2.52M(+101.0%) |
| Mar 2008 | - | -$395.00K(-54.4%) | -$1.25M(-111.6%) |
| Dec 2007 | $10.79M(-54.3%) | -$866.00K(+31.2%) | $10.79M(-7.4%) |
| Sep 2007 | - | -$660.00K(-198.7%) | $11.65M(-5.4%) |
| Jun 2007 | - | $669.00K(-94.3%) | $12.31M(+5.7%) |
| Mar 2007 | - | $11.64M(-630.1%) | $11.64M(-630.1%) |
| Dec 2006 | $23.57M(-39.8%) | - | - |
| Dec 2005 | $39.18M(-189.4%) | - | - |
| Mar 2005 | - | -$2.20M | -$2.20M |
| Dec 2004 | -$43.81M(+8.4%) | - | - |
| Dec 2003 | -$40.40M | - | - |
FAQ
- What is Madrigal Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals annual CFI year-on-year change?
- What is Madrigal Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals quarterly CFI year-on-year change?
- What is Madrigal Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals TTM CFI year-on-year change?
What is Madrigal Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of MDGL is -$274.39M
What is the all time high annual CFI for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high annual cash flow from investing activities is $206.69M
What is Madrigal Pharmaceuticals annual CFI year-on-year change?
Over the past year, MDGL annual cash flow from investing activities has changed by +$228.13M (+45.40%)
What is Madrigal Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of MDGL is $163.88M
What is the all time high quarterly CFI for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high quarterly cash flow from investing activities is $163.88M
What is Madrigal Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, MDGL quarterly cash flow from investing activities has changed by +$65.83M (+67.13%)
What is Madrigal Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of MDGL is -$208.56M
What is the all time high TTM CFI for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high TTM cash flow from investing activities is $206.69M
What is Madrigal Pharmaceuticals TTM CFI year-on-year change?
Over the past year, MDGL TTM cash flow from investing activities has changed by +$9.04M (+4.16%)